These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 593269)

  • 1. Effects of fatty acids on two specific drug binding sites on human serum albumin.
    Birkett DJ; Myers SP; Sudlow G
    Mol Pharmacol; 1977 Nov; 13(6):987-92. PubMed ID: 593269
    [No Abstract]   [Full Text] [Related]  

  • 2. Structural requirements for drug binding to site II on human serum albumin.
    Wanwimolruk S; Birkett DJ; Brooks PM
    Mol Pharmacol; 1983 Nov; 24(3):458-63. PubMed ID: 6195516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of fatty acids on the interaction of 1-anilino-8-naphthalenesulfonate with human plasma albumin.
    Santos EC; Spector AA
    Mol Pharmacol; 1974 May; 10(3):519-28. PubMed ID: 4851749
    [No Abstract]   [Full Text] [Related]  

  • 4. Cephalosporin binding sites to human serum albumin and the relation with the N-B transition of this protein.
    Nerli B; García F; Ballán C; Picó G
    Biochem Mol Biol Int; 1995 May; 36(1):177-84. PubMed ID: 7663413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further characterization of specific drug binding sites on human serum albumin.
    Sudlow G; Birkett DJ; Wade DN
    Mol Pharmacol; 1976 Nov; 12(6):1052-61. PubMed ID: 1004490
    [No Abstract]   [Full Text] [Related]  

  • 6. A fluorescence study of human serum albumin binding sites modification by hypochlorite.
    Lissi E; Alicia Biasutti M; Abuin E; León L
    J Photochem Photobiol B; 2009 Feb; 94(2):77-81. PubMed ID: 19036598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis of the drug-binding specificity of human serum albumin.
    Ghuman J; Zunszain PA; Petitpas I; Bhattacharya AA; Otagiri M; Curry S
    J Mol Biol; 2005 Oct; 353(1):38-52. PubMed ID: 16169013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The characterization of two specific drug binding sites on human serum albumin.
    Sudlow G; Birkett DJ; Wade DN
    Mol Pharmacol; 1975 Nov; 11(6):824-32. PubMed ID: 1207674
    [No Abstract]   [Full Text] [Related]  

  • 9. Binding of drugs to human serum albumin:XI. The specificity of three binding sites as studied with albumin immobilized in microparticles.
    Sjöholm I; Ekman B; Kober A; Ljungstedt-Påhlman I; Seiving B; Sjödin T
    Mol Pharmacol; 1979 Nov; 16(3):767-77. PubMed ID: 530258
    [No Abstract]   [Full Text] [Related]  

  • 10. Crystallographic analysis reveals common modes of binding of medium and long-chain fatty acids to human serum albumin.
    Bhattacharya AA; Grüne T; Curry S
    J Mol Biol; 2000 Nov; 303(5):721-32. PubMed ID: 11061971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug therapy. Binding of drugs to serum albumin (second of two parts).
    Koch-Weser J; Sellers EM
    N Engl J Med; 1976 Mar; 294(10):526-31. PubMed ID: 765821
    [No Abstract]   [Full Text] [Related]  

  • 12. In silico prediction of drug-binding strengths to human serum albumin.
    Colmenarejo G
    Med Res Rev; 2003 May; 23(3):275-301. PubMed ID: 12647311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The identity of the binding sites of bile salts on bovine serum albumin.
    Farruggia B; Picó G
    Res Commun Chem Pathol Pharmacol; 1993 May; 80(2):234-40. PubMed ID: 8321923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative studies of unfolding and binding of ligands to human serum albumin in the presence of fatty acid: spectroscopic approach.
    Varshney A; Ahmad B; Khan RH
    Int J Biol Macromol; 2008 Jun; 42(5):483-90. PubMed ID: 18452986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An analysis of the effect of hypoalbuminemia on the amount of free drug in plasma for drugs bound at two sets of sites.
    Wosilait WD
    Res Commun Chem Pathol Pharmacol; 1974 Dec; 9(4):681-8. PubMed ID: 4456500
    [No Abstract]   [Full Text] [Related]  

  • 16. Binding of 3-carbethoxipsoralen to human serum albumin and human serum: influence of free fatty acids.
    Font G; Mañes J; Martre H; Prognon P; Mahuzier G
    Rev Esp Fisiol; 1987 Sep; 43(3):317-21. PubMed ID: 3423390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Endogenous metabolites as modulators of the transport of drugs by serum albumin].
    Bender KI; Lutsevich NF; Lutsevich AN; Kupchikov VV
    Farmakol Toksikol; 1990; 53(3):72-80. PubMed ID: 2201566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of fatty acids on theophylline binding to human serum albumin. Comparative fluorescence study.
    Maciążek-Jurczyk M; Sułkowska A; Bojko B; Równicka-Zubik J; Szkudlarek-Haśnik A; Zubik-Skupień I; Góra A; Dubas M; Korzonek-Szlacheta I; Wielkoszyński T; Zurawiński W; Sosada K
    Spectrochim Acta A Mol Biomol Spectrosc; 2012 Apr; 89():270-5. PubMed ID: 22286055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of histamine on dimedrol interaction with human serum albumin].
    Bender KI; Lutsevich AN
    Farmakol Toksikol; 1985; 48(2):107-12. PubMed ID: 3996563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmaceutical-grade albumin: impaired drug-binding capacity in vitro.
    Olsen H; Andersen A; Nordbø A; Kongsgaard UE; Børmer OP
    BMC Clin Pharmacol; 2004 Mar; 4():4. PubMed ID: 15046641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.